{"log_id": 1242918517429777849, "direction": 0, "words_result_num": 47, "words_result": [{"probability": {"variance": 0.001051, "average": 0.976342, "min": 0.886893}, "location": {"width": 205, "top": 142, "height": 28, "left": 285}, "words": "第48周活组织检查缺失"}, {"probability": {"variance": 7.5e-05, "average": 0.989691, "min": 0.978084}, "location": {"width": 31, "top": 142, "height": 23, "left": 618}, "words": "10%"}, {"probability": {"variance": 0.002243, "average": 0.96542, "min": 0.898453}, "location": {"width": 40, "top": 138, "height": 24, "left": 824}, "words": "15%"}, {"probability": {"variance": 0.018817, "average": 0.934577, "min": 0.407897}, "location": {"width": 768, "top": 153, "height": 51, "left": 213}, "words": "实验开始时即有可供评价的组织学检查样本的患者 Knodell i炎性坏死基线值评分≥2)"}, {"probability": {"variance": 0.003531, "average": 0.975172, "min": 0.702319}, "location": {"width": 630, "top": 206, "height": 34, "left": 257}, "words": "ell炎性坏死评分相对基线值减少不少于2分月 Knodel纤维化评分无恶化"}, {"probability": {"variance": 0.005672, "average": 0.966753, "min": 0.597567}, "location": {"width": 760, "top": 244, "height": 37, "left": 216}, "words": "对 Ishak纤维化评分来说,改善相对基线值减少不少于1分,恶化=相对基线值增加不"}, {"probability": {"variance": 0.000529, "average": 0.979868, "min": 0.942925}, "location": {"width": 81, "top": 295, "height": 24, "left": 215}, "words": "少于1分"}, {"probability": {"variance": 0, "average": 0.997525, "min": 0.997525}, "location": {"width": 26, "top": 291, "height": 25, "left": 1077}, "words": "局"}, {"probability": {"variance": 7.2e-05, "average": 0.990202, "min": 0.97583}, "location": {"width": 42, "top": 338, "height": 19, "left": 235}, "words": "0.01"}, {"probability": {"variance": 0.023267, "average": 0.926485, "min": 0.388671}, "location": {"width": 682, "top": 363, "height": 37, "left": 204}, "words": "我6:拉米夫定治疗失效患者8周时生化、病毒学、和血学终点A463026"}, {"probability": {"variance": 0.010933, "average": 0.891315, "min": 0.718263}, "location": {"width": 80, "top": 410, "height": 24, "left": 584}, "words": "思替卡韦"}, {"probability": {"variance": 3e-06, "average": 0.998199, "min": 0.995256}, "location": {"width": 82, "top": 404, "height": 28, "left": 808}, "words": "拉米夫定"}, {"probability": {"variance": 0, "average": 0.408819, "min": 0.408819}, "location": {"width": 21, "top": 442, "height": 19, "left": 622}, "words": " me"}, {"probability": {"variance": 0.014197, "average": 0.920944, "min": 0.684262}, "location": {"width": 57, "top": 437, "height": 19, "left": 820}, "words": "100ng"}, {"probability": {"variance": 0, "average": 0.999428, "min": 0.999285}, "location": {"width": 20, "top": 464, "height": 19, "left": 853}, "words": "45"}, {"probability": {"variance": 0.023692, "average": 0.722065, "min": 0.568143}, "location": {"width": 59, "top": 496, "height": 21, "left": 319}, "words": " HBV UN"}, {"probability": {"variance": 0.000503, "average": 0.989916, "min": 0.923533}, "location": {"width": 199, "top": 519, "height": 27, "left": 253}, "words": "达到不可测水平的比例"}, {"probability": {"variance": 0.000258, "average": 0.980285, "min": 0.964219}, "location": {"width": 19, "top": 518, "height": 20, "left": 610}, "words": "9%"}, {"probability": {"variance": 0.016356, "average": 0.871129, "min": 0.74324}, "location": {"width": 21, "top": 515, "height": 21, "left": 838}, "words": "1%"}, {"probability": {"variance": 0.004216, "average": 0.971626, "min": 0.77714}, "location": {"width": 118, "top": 547, "height": 24, "left": 287}, "words": "(<300拷贝/ml"}, {"probability": {"variance": 0.012056, "average": 0.916257, "min": 0.72271}, "location": {"width": 275, "top": 570, "height": 31, "left": 214}, "words": " HBV DNA值较基线值的平均改变"}, {"probability": {"variance": 0.000144, "average": 0.981639, "min": 0.965751}, "location": {"width": 43, "top": 569, "height": 22, "left": 599}, "words": "5.11"}, {"probability": {"variance": 0, "average": 0.998509, "min": 0.998041}, "location": {"width": 46, "top": 565, "height": 21, "left": 826}, "words": "0.48"}, {"probability": {"variance": 0.005739, "average": 0.950264, "min": 0.690121}, "location": {"width": 167, "top": 597, "height": 31, "left": 268}, "words": "(ogi拷贝/mL,PCR)"}, {"probability": {"variance": 0.002836, "average": 0.971585, "min": 0.865116}, "location": {"width": 70, "top": 626, "height": 23, "left": 318}, "words": "ALT复常"}, {"probability": {"variance": 0.000629, "average": 0.932511, "min": 0.903096}, "location": {"width": 34, "top": 621, "height": 20, "left": 601}, "words": "61%"}, {"probability": {"variance": 0.00302, "average": 0.957217, "min": 0.879497}, "location": {"width": 31, "top": 619, "height": 21, "left": 833}, "words": "15%"}, {"probability": {"variance": 0.010377, "average": 0.90967, "min": 0.723089}, "location": {"width": 83, "top": 653, "height": 20, "left": 310}, "words": "(≤1xULN)"}, {"probability": {"variance": 0.011517, "average": 0.912056, "min": 0.760427}, "location": {"width": 132, "top": 677, "height": 25, "left": 284}, "words": " HBEAG血清转换"}, {"probability": {"variance": 0.016239, "average": 0.930802, "min": 0.528779}, "location": {"width": 352, "top": 661, "height": 70, "left": 512}, "words": "PR法(最低检测限300拷贝/m3"}, {"probability": {"variance": 2e-05, "average": 0.995499, "min": 0.991027}, "location": {"width": 21, "top": 675, "height": 20, "left": 607}, "words": "8%"}, {"probability": {"variance": 0.000425, "average": 0.98517, "min": 0.937144}, "location": {"width": 207, "top": 708, "height": 25, "left": 210}, "words": "检测方法: Roche COBAS"}, {"probability": {"variance": 0.000515, "average": 0.981798, "min": 0.932458}, "location": {"width": 59, "top": 750, "height": 22, "left": 207}, "words": "p<0.05"}, {"probability": {"variance": 0.018929, "average": 0.958651, "min": 0.380169}, "location": {"width": 531, "top": 809, "height": 38, "left": 236}, "words": "组织学改善不依赖于 HBY DNA 3t线值ALT水平"}, {"probability": {"variance": 3.9e-05, "average": 0.996105, "min": 0.983697}, "location": {"width": 100, "top": 880, "height": 24, "left": 192}, "words": "试验后随访"}, {"probability": {"variance": 0.010117, "average": 0.973319, "min": 0.379152}, "location": {"width": 731, "top": 905, "height": 41, "left": 234}, "words": "恩替卡韦最佳的治疗时间目前尚不知道,按照3临床方案设计的标准,病人在治疗"}, {"probability": {"variance": 0.004238, "average": 0.969764, "min": 0.651538}, "location": {"width": 776, "top": 945, "height": 41, "left": 189}, "words": "52周后,如果在48周时达到以下应答标准:乙肝病毒被抑制(bDNA法<0.7MEq/ml),e抗"}, {"probability": {"variance": 0.016352, "average": 0.942283, "min": 0.436142}, "location": {"width": 777, "top": 984, "height": 42, "left": 187}, "words": "原消失(e抗原阳性的病人),ALT复常(<1.25UIN,e抗原阴性的病人)则病人将停用本"}, {"probability": {"variance": 0.0186, "average": 0.911593, "min": 0.612069}, "location": {"width": 119, "top": 1038, "height": 24, "left": 187}, "words": "品或拉米大定"}, {"probability": {"variance": 0.002364, "average": 0.982891, "min": 0.716067}, "location": {"width": 733, "top": 1063, "height": 38, "left": 231}, "words": "21%的e抗原阳性的初治病人达到了停药标准,其中81%的病人在24周的随访期中维"}, {"probability": {"variance": 0.002146, "average": 0.981749, "min": 0.752818}, "location": {"width": 780, "top": 1100, "height": 41, "left": 184}, "words": "持应答,85%的e抗原阴性的初治病人达到了停药标准,其中48%的病人在24周的随访期"}, {"probability": {"variance": 0.00995, "average": 0.966642, "min": 0.509599}, "location": {"width": 778, "top": 1138, "height": 43, "left": 185}, "words": "中维特应答。在拉米夫定失效的病人中,极少有病人达到停药标准。这种方案所规定的病人"}, {"probability": {"variance": 0.000421, "average": 0.990689, "min": 0.918693}, "location": {"width": 275, "top": 1186, "height": 33, "left": 185}, "words": "治疗方法不能用作临床实践指南"}, {"probability": {"variance": 0.062783, "average": 0.821429, "min": 0.467078}, "location": {"width": 73, "top": 1260, "height": 24, "left": 184}, "words": "适应症"}, {"probability": {"variance": 0.009262, "average": 0.962914, "min": 0.46922}, "location": {"width": 733, "top": 1280, "height": 46, "left": 227}, "words": "本品适用于病毒复制活跃,血清转氨酶ALT持续升高或肝脏组织学显示有活动性病变"}, {"probability": {"variance": 0.038569, "average": 0.909257, "min": 0.443512}, "location": {"width": 235, "top": 1333, "height": 30, "left": 182}, "words": "的慢性成人乙型肝炎的治疗"}, {"probability": {"variance": 0.010391, "average": 0.907424, "min": 0.687089}, "location": {"width": 100, "top": 1417, "height": 23, "left": 182}, "words": "[用法用量]"}], "language": 3}